赛道爆发！满屏涨停

Core Viewpoint - The article highlights the strong performance of the A-share market, particularly in the computing hardware and innovative pharmaceutical sectors, driven by positive earnings forecasts and favorable policy developments [1][6][9]. Group 1: Computing Hardware Sector - The computing hardware stocks experienced a collective surge, with PCB and CPO sectors leading the gains. Notable stocks included Mankun Technology and Dongshan Precision, both hitting the daily limit up [2][3]. - Dongshan Precision reported that its soft board business is a core support due to its positioning in consumer electronics and new energy vehicles, while its hard board business benefits from the growth in 5G communication and data centers [5]. - Guohua Technology anticipates a net profit of 485 million to 505 million yuan for the first half of 2025, representing a year-on-year increase of 51.85% to 58.12%, driven by the demand for computing infrastructure fueled by AI technology [4]. Group 2: Innovative Pharmaceutical Sector - The innovative pharmaceutical sector showed robust performance, with stocks like Weikang Pharmaceutical and Fudan Zhangjiang hitting the daily limit up. Fudan Zhangjiang's stock price surged nearly 14% [6][7]. - Recent policy releases, such as the initiation of the 11th batch of national drug centralized procurement, favor innovative drugs by excluding them from centralized procurement, thus enhancing their market access [9]. - Pharmaceutical companies like WuXi AppTec and Ganli Pharmaceutical reported significant earnings growth, with WuXi AppTec projecting a 20.64% increase in revenue and a 44.43% rise in net profit for the first half of the year [9][10].